Bengaluru, 17th Aug 2021
:
OMRON Healthcare India, the leading player in the “digital
home blood pressure monitoring” segment, has announced the initiation of India’s first-of-its-kind AI-based collaborative trial program in the field of
remote patient monitoring. The program, targeted at patients that have undergone surgical
procedures or ablation for the treatment of cardiovascular diseases,
aims to establish
the relevance & role of remote hypertension & ECG monitoring
for strengthening the treatment & care regime to reduce
cardiovascular complications and deaths.
According
to worldwide surveys on human atrial fibrillation, around 27% of the
patients experience recurrence of atrial fibrillation (AFib) after
ablation treatment. This underlines
the importance of real-time and continuous monitoring of ECG along with
blood pressure at home in order to help the doctors take more informed
and timely decisions.
“OMRON
aims to expand its presence in the remote patient monitoring segment
which is gaining lot of significance in the healthcare ecosystem of
India. Post collaborating with varied
AI based healthcare applications in the personal healthcare monitoring
domain, we are all set to move ahead and strengthen our value addition
in the hospital care management with this endeavor. With the right
partners on board, we are optimistic of receiving
good results from the trial. It will help us to propel ahead our vision
of ‘Going for Zero’ cardiovascular diseases by collaborating OMRON’s
vital sensing technology with AI of Tricog & doctors’ support at
Sakra World Hospital,” said
Masanori Matsubara, MD, OMRON Healthcare India.
The study in the trial will explore two core possibilities - how technology can
enable monitoring of ECG at home and how AI can
enable timely intervention in the postoperative cardiovascular patients.
The
aim is to achieve further improvement of cardiovascular disease
management coupled with high blood pressure management in a remote
environment.
About the trial:
OMRON
Complete™ Blood Pressure monitor equipped with ECG capabilities is
provided to Sakra World Hospital’s patients, Bengaluru, who have
undergone surgical / ablation cardiovascular procedures.
At discharge, patients are trained to use the OMRON device to measure
their BP and ECG at home daily. The Vital signs and the ECG data are
transmitted to Tricog Health, one of the world’s largest Health AI
companies, that provides AI-enabled real-time monitoring
of the patient’s condition. Using Tricog’s platform and proprietary AI
technology, the multidisciplinary care team of Sakra World hospital
monitors the health of their patients, enabling remote diagnosis of
life-threatening conditions and preventing complications
before they occur. In addition, the patients can connect with Sakra
World Hospital’s experts from the comfort of their homes 24x7.
According to
Dr Charit Bhograj, Founder and CEO of Tricog Health, “Our vision
is to enable access to the best of medical care, that is majorly
available at tertiary care hospitals only, to the patients at home and
that too at the time they need it the most. Empowering
doctors to save more lives with the help of innovative technology and
advanced AI algorithms is the future of healthcare where problems are
detected before they lead to serious adverse events. We are happy to
find it completely in sync with OMRON’s vision
of ‘Going For Zero’ cardiovascular events and hope to achieve a
significant milestone in the remote cardiac healthcare management sector
in India with this trial.”
Dr Sreekanth of Sakra World Hospital, Bangalore
said "For patients
with blood pressure, risk of heart arrhythmias and stroke is persistent
and threatening over the long term. Identifying intermittent
out-of-hospital events will help early initiation of appropriate
treatment. Monitoring heart rhythm need not end at the moment
of discharging patient from the hospital. This trial will show us how
the device and analysis on the data will effectively improve the patient
care after discharging patients of cardiovascular diseases."
As
per World Heart Federation, Cardiovascular disease, including heart
disease and stroke, is the most common non-communicable disease
globally, responsible for an estimated 18.5 million deaths,
of which more than three quarters occur in low-income and middle-income
countries (including India). By the year 2030, the UN Sustainable
Development Goals aim to reduce premature mortality from
non-communicable diseases by a third.
Hypertension,
the ‘silent killer’ has long been recognized as one of the major risk
factors for cardiovascular disease and premature deaths worldwide.
According to the World Health Organization,
in 2015, raised BP was responsible for 7.5 million deaths, about 12.8
per cent of the total of all deaths globally.
In
India, it is a growing problem and causes significant burden on the
health system. According to the GBD study, hypertension led to 1.63
million deaths in India in the year 2016 alone.
It also showed that over half of the deaths due to ischemic heart
disease (54.2%), stroke (56.2%) and chronic kidney disease (54.5%) were
attributable to high systolic BP. A cross-sectional, population-based study on a large nationally representative
sample of 1.3 million individuals revealed that the crude prevalence of hypertension in India was 25.3 per cent
between 2012 and 2014. Its prevalence is common even among younger age
groups. It says approximately one out of every 10 individuals aged
18-25 suffers from it.
In
2015, OMRON Healthcare announced its Going for Zero vision for its
cardiovascular business, with the goal of achieving zero cardiovascular
events, expanding its business domain from
blood pressure measurement to innovative devices including a wearable
blood pressure monitor, and healthcare management services across the
globe. Along with India, the company has also rolled out remote patient
monitoring services in US, UK and Singapore.
Under these new services, biological data sets, measured at home, can
be shared with healthcare professionals, supporting them with better
insight in their patients’ health conditions and required treatment
plans, contributing to the Going for Zero vision.
***
About OMRON Healthcare India:
Committed
to helping people live more active and fulfilling lives, OMRON
Healthcare is a global leader in the field of clinically proven,
innovative medical equipment for health monitoring
and therapy. Throughout its history, OMRON Healthcare has been striving
to improve lives and contribute to a better society by developing
innovations that help people prevent, treat and manage their medical
conditions, both at home and in clinical practice
in over 110 countries.
The
OMRON Healthcare Group, headquartered in Kyoto, Japan, provides World’s
No.1 blood pressure monitors (Global Home Appliance Market
Comprehensive Survey 2020 by Fuji Keizai Co.,Ltd.(2019)).
The company’s additional core product categories are respiratory care,
pain management devices, and wellness products. It also develops and
activates remote patient monitoring service in the field of
cardiovascular condition management.
Established
in 2010, OMRON Healthcare India has established itself a key player in
the health monitoring segment in the country providing high quality
blood pressure monitors, respiratory
therapy devices, body fat monitors, digital thermometers, pain
management devices, etc. It
is the most recommended brand by doctors for blood pressure monitors
and has been making rapid strides in the nebulizers segment too.
To learn more, please visit:
https://www.omronhealthcare-ap.com/in;
https://www.omronbrandshop.com/
About Tricog:
Established
in 2015, Tricog Health is a Singapore based healthcare company that
leverages technology and medical expertise to make quality cardiac care
accessible to every patient across the globe.
With virtual diagnostic services that provide an accurate, timely and
consistent diagnosis of cardiac conditions, today, Tricog has already
served more than 6M patients by aiding 12K healthcare providers across
the globe through a suite of cloud-based, AI-aided
services - InstaECG and InstaEcho. Tricog solution continues to save
precious lives by timely prediction and detection of cardiovascular
ailments enabling timely treatment.
